99586-65-9

Basic information

• Product Name: 4-Chloropyridine-2-carboxamide
• Synonyms: 4-Chloro-2-picolinamide;4-Chloropyridine-2-carboxamide ,95%;4-Chloropyridine-2-c;2-PyridinecarboxaMide,4-chloro;4-Chloropicolinamide, 2-Carbamoyl-4-chloropyridine;IFLAB-BB F2108-0034;4-CHLOROPICOLINAMIDE;4-CHLORO-PYRIDINE-2-CARBOXYLIC ACID AMIDE
• CAS NO: 99586-65-9
• Molecular Formula: C₆H₅ClN₂O
• Molecular Weight: 156.57
• Product Categories: NULL;blocks;Carboxes;Pyridines;Pyridine series;Pyridine
• Mol File: 99586-65-9.mol

Chemical Properties

• Melting Point: 148-152
• Boiling Point: 298.1 °C at 760 mmHg
• Flash Point: 134.1 °C
• Appearance: Off-white/Solid
• Density: 1.381 g/cm³
• Vapor Pressure: 0.0013mmHg at 25°C
• Refractive Index: 1.588
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 14.49±0.50(Predicted)
• CAS DataBase Reference: 4-Chloropyridine-2-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Chloropyridine-2-carboxamide(99586-65-9)
• EPA Substance Registry System: 4-Chloropyridine-2-carboxamide(99586-65-9)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 22
• HazardClass: IRRITANT
• Hazardous Substances Data: 99586-65-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
4-Chloropyridine-2-carboxamide is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to form diverse chemical structures, contributing to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
4-Chloropyridine-2-carboxamide is utilized as a precursor in the production of agrochemicals, specifically in the synthesis of pesticides and herbicides, due to its reactivity and potential to create effective active ingredients.
Used in Dye and Pigment Industry:
4-Chloropyridine-2-carboxamide is employed as a starting material in the synthesis of dyes and pigments, where its chemical properties allow for the creation of a variety of colorants used in different industries such as textiles, plastics, and printing inks.
Used in Research and Development:
4-Chloropyridine-2-carboxamide is used as a research chemical in academic and industrial laboratories, where it is studied and manipulated to understand its properties and explore its potential applications in various fields, including materials science and medicinal chemistry.

InChI:InChI=1/C6H5ClN2O/c7-4-1-2-9-5(3-4)6(8)10/h1-3H,(H2,8,10)

Upstream product

• 24484-93-3 4-Chloro-pyridine-2-carboxylic acid methyl ester 
• 7664-41-7 ammonia 
• 19235-89-3 4-chloro-pyridine-2-carbonitrile 
• 53750-66-6 4-chloro-pyridine-2-carbonyl chloride 
• 1121-76-2 4-chloropyridine N-oxide 
• 176977-85-8 methyl 4-chloropyridine-2-carboxylate hydrochloride 
• 5470-22-4 4-chloropicolinic acid 
• 75-44-5 phosgene 
• 284462-78-8 4-(3-aminophenoxy)-N-methylpicolinamide 
• 51727-15-2 4-chloro-2-pyridine carboxylic acid chloride hydrochloride 
• 349-65-5 2-Methoxy-5-trifluoromethyl-aniline 
• 284462-37-9 4-(4-aminophenoxy)-N-methylpyridine-2-carboxamide 
• 327-78-6 4-chloro-3-(trifluoromethyl)phenyl isocyanate 
• 284462-80-2 4-(4-aminophenoxy)-2-pyridinecarboxamide 

Downstream Products

• 19798-80-2 2-Amino-4-chloropyridine 
• 757251-54-0 4-(4-amino-3-fluorophenoxy)pyridine-2-carboxyamide 
• 928038-30-6 4-(3-Fluoro-4-{[1-(4-fluorophenylcarbamoyl)cyclopropanecarbonyl] amino }phenoxy)pyridine-2-carboxamide 
• 868736-13-4 4-(4-amino-2,5-difluorophenoxy)picolinamide 
• 868735-84-6 4-(4-amino-2,3-difluorophenoxy)picolinamide 
• 868735-85-7 4-(6-amino-2,3-diflurophenoxy)pyridine-2-carboxamide 
• 952490-94-7 4-(4-benzyloxy-phenoxy)-pyridine-2-carboxylic acid amide 
• 769961-47-9 4-(3-amino-4-hydroxy-phenoxy)-pyridine-2-carboxylic acid amide 
• 952490-72-1 4-(4-hydroxy-3-nitro-phenoxy)-pyridine-2-carboxylic acid amide 
• 868733-71-5 4-(4-amino-2-fluorophenoxy)pyridin-2-carboxamide 
• 757251-55-1 4-(4-amino-2-chlorophenoxy)picolinamide 
• 284462-79-9 4-(3-aminophenoxy)pyridine-2-carboxamide 
• 284462-80-2 4-(4-aminophenoxy)-2-pyridinecarboxamide 
• 320-51-4 4-chloro-3-trifluoromethyl-aniline 

Relevant articles and documents

Preparation method of 2-cyano-4-fluoropyridine

The invention discloses a preparation method of 2-cyano-4-fluoropyridine, which comprises the steps of by using 4-chloropyridine-2-methyl formate as a raw material, carrying out ester ammonolysis reaction, amide dehydration reaction and halogen exchange reaction to prepare the 2-cyano-4-fluoropyridine. The method is simple in synthesis process, mild in reaction condition, high in yield and good inproduct purity; the used raw materials are easy to obtain and low in cost, and the preparation method is suitable for industrial production.

Synthesis method of imidazopyridine or pyrimidine derivative

The invention belongs to the technical field of synthesis, and particularly relates to a synthesis method of an imidazopyridine or pyrimidine derivative. The imidazopyridine or pyrimidine compound is obtained by taking pyridine or pyrimidinecarboxylic acid as a synthon through amidation, Hofmann degradation and cyclization reaction, and the obtained imidazopyridine or pyrimidine derivative can be further converted to generate a functional product. The method has the advantages of easily available raw materials, simple operation, high reaction efficiency, convenient post-treatment, and diversity of functional groups.

Synthesis method of Tucatinib and intermediate product thereof

The invention discloses a synthesis method of Tucatinib, and the method comprises the following step: carrying out substitution reaction on halate of a compound shown in a formula VI or free alkali thereof serving as a raw material and a compound shown in a formula VII under an alkaline condition to obtain a compound shown in a formula VIII. The raw materials used in the whole synthesis route areeasy to obtain, expensive catalysts are not needed, and the method is suitable for large-scale production and beneficial to industrial production of the Tucatinib.

Preparation method of 2-amino-4-fluoropyridine

The invention discloses a preparation method of 2-amino-4-fluoropyridine, comprising the synthetic steps of 1, subjecting 2-pyridinecarboxylic acid as a raw material to reaction in the presence of thionyl chloride and a salt to obtain 4-chloropyridine-2-acyl chloride, and subjecting 4-chloropyridine-2-acyl chloride the presence of ammonia to obtain 4-chloropyridine-2-amide; 2, subjecting 4-chloropyridine-2-amide to Hofmann rearrangement reaction to obtain 2-amino-4-chloropyridine; 3, subjecting 2-amino-4-chloropyridine to halogen exchange to obtain 2-amino-4-fluoropyridine. The problems of theexisting preparation method, such as long synthetic path, operational complexity, high pollution of three wastes, poor atomic economy, low yield and high manufacture cost, are solved.

Transition-metal-free synthesis of primary to tertiary carboxamides: A quick access to prodrug-pyrazinecarboxamide

One-pot expedient and direct carbamoylation of heterocyclics is described. The transformation is realized via direct dehydrogenative aminocarbonylation of heterocyclic compounds under transition-metal-free conditions. This method is regioselective and the protocol is proved to be scalable on a gram scale. Further, the therapeutically useful antitubercular agent pyrazinecarboxamide is successfully synthesized by employing this protocol.

ARYL UREAS WITH ANGIOGENISIS INHIBITING ACTIVITY

This invention relates to methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes.

As opioid receptor antagonists or inverse agonists of the novel compounds

Novel compounds which are antagonists or inverse agonists at one or more of the opioid receptors, pharmaceutical compositions containing them, to processes for their preparation.

SUBSTITUTED PYRAZOLONE COMPOUNDS AND METHODS OF USE

The present invention provides novel substituted pyrazolone compounds, pharmaceutical acceptable salts and formulations thereof useful in modulating the protein tyrosine kinase activity, and in modulating cellular activities such as proliferation, differentiation, apoptosis, migration and invasion. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.

Aryl ureas as kinase inhibitors

This invention relates to new aryl ureas and methods for their synthesis. The inventive compounds are useful in the treatment of (i) raf mediated diseases, for example, cancer, (ii) p38 mediated diseases such as inflammation and osteoporosis, and (iii) VE

Discovery of nitropyridine derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitors via a structure-based core refining approach

As a continuation of our efforts to discover and develop back-up analogs of DAPYs, novel substituted nitropyridine derivatives were designed via a structure-based core refining approach, synthesized and evaluated for their in vitro HIV-1 activity in MT-4 cells. Preliminary biological evaluation indicated that most of the compounds exhibited marked inhibitory activity against wild-type HIV-1 IIIB. Most notably, the compound 7b was identified as the most promising candidate in inhibiting HIV-1 replication with an EC 50 value of 0.056 μM and a selective index (SI) of 1251, which were much better than those of NVP (EC50 = 0.23 μM) and DLV (EC50 = 0.51 μM). Some other compounds, 7k, 7c, 7j and 7e, were also endowed with a favorable anti-HIV-1 potency (EC50 = 0.034, 0.11, 0.11 and 0.16 μM, respectively). Some antivirally active compounds also showed moderate inhibitory activity against RT. Preliminary structure-activity relationships (SARs) and molecular modeling of these new analogs provide valuable avenues for future molecular optimization.